2022
DOI: 10.3390/molecules27207074
|View full text |Cite
|
Sign up to set email alerts
|

(−)-Adaline from the Adalia Genus of Ladybirds Is a Potent Antagonist of Insect and Specific Mammalian Nicotinic Acetylcholine Receptors

Abstract: Ladybird beetles (Coleoptera: Coccinellidae) possess strong chemical defences that are secreted in response to stress and are also found on the coating of eggs, which are rich in alkaloids that are responsible for their toxicity to other species. Recent studies have shown that alkaloids from several species of ladybird beetle can target nicotinic acetylcholine receptors (nAChRs) acting as receptor antagonists. Here, we have explored the actions of (−)-adaline, found in the 2-spot (Adalia bipunctata) and 10-spo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 48 publications
0
1
0
Order By: Relevance
“…Given that most α3β4-targeting compounds are derived from alkaloids (e.g., ibogaine, cytisine) or naturally occurring peptide toxins, natural products are likely to be a fruitful source of new compounds. Indeed, the recent discovery of several natural products, including the Aristotelia alkaloids, philanthotoxins, and ladybird alkaloids, with α3β4-subtype selectivity indicates that promising new classes of compounds ripe for further development may already exist. …”
Section: Summary and Outlook For α3β4 Inhibitorsmentioning
confidence: 99%
“…Given that most α3β4-targeting compounds are derived from alkaloids (e.g., ibogaine, cytisine) or naturally occurring peptide toxins, natural products are likely to be a fruitful source of new compounds. Indeed, the recent discovery of several natural products, including the Aristotelia alkaloids, philanthotoxins, and ladybird alkaloids, with α3β4-subtype selectivity indicates that promising new classes of compounds ripe for further development may already exist. …”
Section: Summary and Outlook For α3β4 Inhibitorsmentioning
confidence: 99%